Why is Fischer Medical falling/rising?

As of 01-Sep, Fischer Medical Ventures Ltd's stock price is currently at 1,051.10, reflecting an increase of 8.75 (0.84%). The stock has shown a trend reversal, gaining after three consecutive days of decline, and is now just 3.23% away from its 52-week high of Rs 1085. The stock's performance over the past month has been strong, with a return of +9.92%, while it has outperformed the benchmark Sensex over the last year with a return of +68.19%. Positive factors contributing to this rise include a low debt-to-equity ratio and impressive growth in net sales and profit after tax, which have increased significantly in recent months. However, concerns about management efficiency and a high price-to-book value indicate potential risks that may temper investor enthusiasm.
In the broader market context, Fischer Medical's short-term performance has been better than the benchmark, as it has declined by only 2.13% over the past week compared to the Sensex's decline of 1.56%. This relative strength, combined with rising investor participation and liquidity, suggests that the stock is attracting interest despite some underlying risks. The company's consistent returns over the past three years further bolster its appeal, even as domestic mutual funds remain hesitant to invest, indicating a cautious outlook among institutional investors.